CLBT — Cellebrite DI Ltd.
—
Nasdaq ·
Information Technology ·
Software ·
CIK 1854587 ·
Last close
$15.94
Market Cap
$3.98B
52W High
$17.05
52W Low
$11.05
ADV30
2,211,529
Next earnings
2026-05-14
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 128,301,000 | 105,881,000 | 9,119,000 | 10,938,000 | 952,286,000 | 133,689,000 | 441,746,000 |
| Dec 2025 | 128,821,000 | 109,130,000 | 20,805,000 | 21,261,000 | 938,852,000 | 124,457,000 | 454,534,000 |
| Sep 2025 | 126,029,000 | 105,715,000 | 18,990,000 | 20,189,000 | 834,319,000 | 281,361,000 | 386,634,000 |
| Jun 2025 | 113,276,000 | 95,599,000 | 14,417,000 | 19,476,000 | 787,425,000 | 179,223,000 | 379,012,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$173,544,000
Investing CF
$-268,250,000
Financing CF
$25,053,000
CapEx
$-13,225,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.31
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-86,538,000
Inventory
$7,603,000
Receivables
$104,972,000
ST Investments
$312,593,000
EBIT TTM
$104,715,000
Pretax Income TTM
$90,678,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$496,427,008
EBITDA
$79,572,000
Free Cash Flow
$149,560,880
Enterprise Value
$3,569,299,456
Total Cash
$429,068,000
Total Debt
$22,805,000
Shares Out
249,439,817
Trailing EPS
$0.28
Book Value
$2.07
ROE
16.4%
ROA
4.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 475,675,000 | 66,480,000 | 78,326,000 | 938,852,000 | 454,534,000 | — | 173,544,000 |
| Dec 2024 | 401,203,000 | 56,906,000 | -283,007,000 | 690,567,000 | 354,547,000 | — | 132,171,000 |
| Dec 2023 | 325,110,000 | 33,237,000 | -81,100,000 | 532,885,000 | 498,673,000 | — | 102,058,000 |
| Dec 2022 | 270,651,000 | 1,044,000 | 120,805,000 | 403,293,000 | 329,428,000 | — | 20,577,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.66
Max Pain — expiry 2026-07-17
max pain strike: $12.50 · spot: $15.94 · call oi: 6,302 · put oi: 1,566
Expected Move to 2026-07-17:
±$1.38
(8.63%) —
implied range
$14.56 –
$17.31
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BOX | BOX INC | $3.97B | $28.64 | — |
| BILL | BILL Holdings, Inc. | $4.12B | $41.36 | — |
| APPF | APPFOLIO INC | $4.22B | $175.58 | — |
| OCTV | Octave Intelligence plc | $4.38B | $17.00 | — |
| TENB | Tenable Holdings, Inc. | $4.39B | $39.78 | — |
News headlines (Yahoo Finance, 1h cache)
Cellebrite Expands Exclusive SkySafe Partnership to Deliver Immediate Drone Detection and Airspace Intelligence for Digital Investigations at Scale
2026-07-08 12:30 · Yahoo
Cellebrite (CLBT)’s Total Addressable Market Is Large, Growing, And Likely Understated, According To DA Davidson
2026-06-20 20:35 · Yahoo
Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now?
2026-06-19 16:20 · Yahoo
Cognyte's Recurring Revenue Shift: Short-Term Strain Ahead?
2026-06-12 14:09 · Yahoo
Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available
2026-06-10 12:30 · Yahoo
Cellebrite Announces Upcoming Investor Events on June 10, 2026
2026-06-05 12:00 · Yahoo
Tracking How the Cellebrite (CLBT) Investment Narrative Is Evolving Without New Analyst Targets
2026-06-04 19:11 · Yahoo
Cognyte to Report Q1 Earnings: How Should Investors Play the Stock?
2026-06-01 13:38 · Yahoo
Stride Stock Is Down 40% This Past Year. Here's Why One Investor Added $58 Million
2026-05-30 00:08 · Yahoo
Choice Hotels Stock Is Down 15%, but One Investor Bought $101 Million Last Quarter
2026-05-30 00:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.